Morningside Venture Investments Ltd's Form 4 filing
GreenLight Biosciences Holdings, PBC (GRNA) · filed Feb 4, 2022
- Accession no.
- 0000899243-22-004855
- Filed
- Feb 4, 2022
- Trade date
- Feb 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morningside Venture Investments LtdCIK 0001543112 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Common Stock | CConversionAcquired | +12,858,188 | – | – | 12,858,188 | Direct | |
| Feb 2, 2022 | Common Stock | PPurchaseAcquired | +1,000,000 | – | – | 13,858,188 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Common Stock | CConversionDisposed | −12,858,188 | $0.00 | $0 | 0 | Direct | |
| Feb 2, 2022 | Common Stock | CConversionDisposed | −1,000,000 | $10.00 | −$10,000,000 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.